Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide Technologies at Energypolis.

Marc Mathieu1, Origène Nyanguile2

  • 1HES-SO Valais-Wallis, Institute of Life Technologies, Campus Energypolis, Route de Rawyl 47, CH-1950 Sion, Switzerland.

Chimia
|July 8, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double-Stapled Peptide Scan Yields Potent Fusion Inhibitors of Respiratory Syncytial Virus.

Journal of medicinal chemistry·2026
Same author

Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release.

Chemical science·2024
Same author

Cartilage regeneration in zebrafish depends on Nrg1/ErbB signaling pathway.

Frontiers in cell and developmental biology·2023
Same author

Template directed synthesis of antibody Fc conjugates with concomitant ligand release.

Chemical science·2022
Same author

NRG1/ErbB signalling controls the dialogue between macrophages and neural crest-derived cells during zebrafish fin regeneration.

Nature communications·2021
Same author

Long non-coding RNA exploration for mesenchymal stem cell characterisation.

BMC genomics·2021
Same journal

How Much Chirality is Enough?

Chimia·2026
Same journal

Raman Optical Activity (ROA) as an Emerging Standard in Molecular Chirality Measurements - A Perspective.

Chimia·2026
Same journal

Molecular Chirality: From Structure to the Quantum Dynamics of Tunnelling, Parity Violation, a Molecular Quantum Switch and the Possible Astrophysical Detection of Homochirality as a Signature of Extraterrestrial Life.

Chimia·2026
Same journal

Shining Light on Chiral Monolayer-protected Metal Clusters.

Chimia·2026
Same journal

Spin Depolarization Mechanisms in Halide Perovskite Semiconductors.

Chimia·2026
Same journal

New Insights into Circularly Polarized Luminescence from Chromium(III) Spin-Flip Emitters.

Chimia·2026
See all related articles

Researchers are developing advanced peptide technologies for cancer imaging, infectious disease treatment, and drug delivery. These innovations aim to create novel biomaterials and therapeutic solutions.

Area of Science:

  • Biotechnology
  • Medicinal Chemistry
  • Materials Science

Background:

  • The Energypolis campus unites EPFL Valais-Wallis, HES-SO Valais-Wallis, and the Ark Foundation.
  • This collaboration focuses on critical areas: energy, health, and environmental technologies.
  • The campus fosters innovation and startup creation in these scientific domains.

Purpose of the Study:

  • To review current peptide technology developments within the Institute of Life Technologies.
  • To highlight advancements in therapeutic antibody labeling, antiviral/antimicrobial peptides, drug-peptide conjugates, and biomaterial engineering.

Main Methods:

  • Regioselective labeling of therapeutic antibodies.
  • Development of peptide-based antivirals and antimicrobials.

Related Experiment Videos

  • Conjugation of drugs to peptidic scaffolds.
  • Engineering of novel biomaterials.

    • Main Results:

    • Progress in regioselective labeling for enhanced cancer imaging.
    • Advancements in peptide antivirals and antimicrobials for infectious diseases.
    • Development of targeted drug delivery systems using peptide conjugates.
    • Innovations in peptide-based biomaterials.

    Conclusions:

    • Peptide technologies are rapidly advancing across multiple therapeutic and diagnostic areas.
    • These developments hold significant promise for future medical treatments and diagnostics.
    • The Institute of Life Technologies is at the forefront of peptide innovation.